Compounds > 1-anilino-8-naphthalenesulfonate
Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Cytokine Release Syndrome

1-anilino-8-naphthalenesulfonate has been researched along with Cytokine Release Syndrome in 1 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ganesh, PS1
Vishnupriya, S1
Vadivelu, J1
Mariappan, V1
Vellasamy, KM1
Shankar, EM1

Reviews

1 review available for 1-anilino-8-naphthalenesulfonate and Cytokine Release Syndrome

ArticleYear
Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors.
    Microbiology and immunology, 2020, Volume: 64, Issue:2

    Topics: Animals; Biofilms; Burkholderia cepacia; Burkholderia cepacia complex; Burkholderia Infections; Comm

2020